| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $359.1M | +8.0% | +24.0% |
| Cost of Revenue | $127.6M | +3.6% | +15.6% |
| Gross Profit | $231.5M | +10.5% | +29.2% |
| R&D Expense | $83.3M | +6.4% | +18.6% |
| SG&A Expense | $48.3M | -0.4% | +15.8% |
| Operating Income | $38.4M | +108.0% | +227.9% |
| Pre-tax Income | $74.6M | +204.3% | +273.3% |
| Income Tax | $14.4M | +312.2% | +351.2% |
| Net Income | $60.1M | +92.0% | +261.3% |
| EPS (Basic) | $0.71 | +91.9% | +257.8% |
| EPS (Diluted) | $0.70 | +94.4% | +255.6% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $407.9M | -17.1% | -41.5% |
| Short-term Investments | $511.2M | -1.7% | +8.4% |
| Accounts Receivable | $162.9M | +72.2% | +32.5% |
| Current Assets | $1.35B | -0.8% | -8.9% |
| Total Assets | $2.69B | +2.0% | +5.9% |
| Current Liabilities | $459.0M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $44.6M | +166.2% | — |
| Capital Expenditures | $8.2M | +67.3% | — |
| Investing Cash Flow | -$204.6M | -47.4% | — |
| Financing Cash Flow | -$134.3M | — | — |
| Free Cash Flow | $36.5M | +150.5% | — |
| -17.8% |
| Total Liabilities | $1.18B | +6.8% | -7.3% |
| Stockholders' Equity | $1.51B | -1.5% | +19.1% |